Publications

Explore our publications to find useful evidence, lessons and recommendations from our work across Africa and Asia

SIGN UP TO THE PUBLICATIONS NEWSLETTER
Stemming the rising tide of global dengue


Position statement

Stemming the rising tide of global dengue

Dengue is the world’s fastest growing vector-borne disease. To tackle it, we urgently need to increase funding for vaccine development, improve real-time case surveillance systems, strengthen vector control tools, amplify community engagement and enhance global collaboration.

  
Implementation of guppy fish and a novel larvicide for dengue control in Cambodia


Journal article

Implementation of guppy fish and a novel larvicide for dengue control in Cambodia

This qualitative study aims to better understand the community acceptance and perceptions of biological controls that would overcome insecticide resistance, for consideration in dengue control strategies for the future.

  
Controlling vectors and engaging communities to prevent dengue in Cambodia


Project brief

Controlling vectors and engaging communities to prevent dengue in Cambodia

To prevent and limit dengue transmission, we trialled a socio-ecological vector control strategy using guppy fish distribution for larval source control, and the introduction of low-cost mosquito traps, combined with social interventions.

  
Dengue situation in Bangladesh: An epidemiological shift in terms of morbidity and mortality


Journal article

Dengue situation in Bangladesh: An epidemiological shift in terms of morbidity and mortality

In this study, climatic changes and rapid unplanned urbanization were strong predictors of an ecological imbalance that led to increased dengue cases in 2016, and the emergence of chikungunya virus in Bangladesh in 2017.

  
Reset all search optionsCurrent search filters (27 results match ALL terms):
Chad
26/08/2020 Project brief Chimioprévention du paludisme saisonnier: Protéger les enfants de moins de cinq ans contre le paludisme durant les pics de transmission saisonniers En 2020, Malaria Consortium s’est donné pour objectif d’atteindre plus de 12 millions d’enfants au Burkina Faso, au Tchad et au Nigeria par le biais de son programme CPS, notamment… 26/08/2020 En 2020, Malaria Consortium s’est donné pour objectif d’atteindre plus de 12 millions d’enfants au Burkina Faso, au Tchad et au Nigeria par le biais de son programme CPS, notamment grâce aux efforts de plus de 100 000 personnes.
26/08/2020 Project brief Quimioprevenção sazonal da malária: Proteger os menores de cinco anos contra a malária durante a época alta de transmissão Em 2020, o programa de SMC da Malaria Consortium tem como objetivo chegar a mais de 12 milhões de crianças no Burquina Faso, Chade e Nigéria através dos esforços de… 26/08/2020 Em 2020, o programa de SMC da Malaria Consortium tem como objetivo chegar a mais de 12 milhões de crianças no Burquina Faso, Chade e Nigéria através dos esforços de mais de 100.000 pessoas.
29/07/2020 Project brief Seasonal malaria chemoprevention: Protecting children under five from malaria during peak transmission season In 2020, Malaria Consortium's SMC programme aims to reach more than 12 million children in Burkina Faso, Chad and Nigeria. 29/07/2020 In 2020, Malaria Consortium's SMC programme aims to reach more than 12 million children in Burkina Faso, Chad and Nigeria.
05/05/2020 Annual review Seasonal malaria chemoprevention program Philanthropy Report 2019-2020 Malaria Consortium’s annual report on the use of philanthropic funding for seasonal malaria chemoprevention 05/05/2020 Malaria Consortium’s annual report on the use of philanthropic funding for seasonal malaria chemoprevention
24/01/2020 Advocacy briefs Strong health systems save lives: Improving pneumonia case management at all levels Pneumonia is the leading infectious cause of death among children under five, yet it is preventable, treatable and curable. 24/01/2020 Pneumonia is the leading infectious cause of death among children under five, yet it is preventable, treatable and curable.
28/01/2019 Learning paper Seasonal chemoprevention as an effective malaria preventive strategy for children in the Sahel This paper shares learning and recommendations from the Achieving Catalytic Expansion of Seasonal Malaria Chemoprevention in the Sahel (ACCESS-SMC) project, which was launched in 2015 to overcome barriers to seasonal… 28/01/2019 This paper shares learning and recommendations from the Achieving Catalytic Expansion of Seasonal Malaria Chemoprevention in the Sahel (ACCESS-SMC) project, which was launched in 2015 to overcome barriers to seasonal malaria chemoprevention (SMC) scale-up. By supporting national malaria control/elimination programmes…
11/12/2018 Annual review Trustees' report and financial statements for the year to 31 March 2018 Malaria Consortium's Trustees present their report and the audited financial statements for the year which ended 31 March 2018. 11/12/2018 Malaria Consortium's Trustees present their report and the audited financial statements for the year which ended 31 March 2018.
21/09/2018 Advocacy briefs Malaria Consortium and the Sustainable Development Goals At Malaria Consortium, we strive to ensure that our work contributes to achieving the Global Goals for Sustainable Development (SDGs) by 2030. We support the countries in which we operate… 21/09/2018 At Malaria Consortium, we strive to ensure that our work contributes to achieving the Global Goals for Sustainable Development (SDGs) by 2030. We support the countries in which we operate to ensure their citizens are free from the burden of…
30/08/2018 Infographic Impact: Malaria Consortium and seasonal malaria chemoprevention Malaria Consortium has been distributing preventive treatments to children under five across the Sahel region to protect them from malaria during the past four rainy seasons. Case-control studies have found… 30/08/2018 Malaria Consortium has been distributing preventive treatments to children under five across the Sahel region to protect them from malaria during the past four rainy seasons. Case-control studies have found that one treatment course of seasonal malaria chemoprevention (SMC) per…
04/05/2018 Presentation Scaling up access to seasonal malaria chemoprevention in the Sahel Diego Moroso, Project Director for ACCESS-SMC, presented the feasibility, safety and effectiveness of seasonal malaria chemoprevention (SMC) at scale at the 2018 Multilateral Initiative on Malaria cConference. There is an… 04/05/2018 Diego Moroso, Project Director for ACCESS-SMC, presented the feasibility, safety and effectiveness of seasonal malaria chemoprevention (SMC) at scale at the 2018 Multilateral Initiative on Malaria cConference. There is an estimated gap of 12 to 18 million children who could…
06/03/2018 Case study Le récit de Gassara: “Si la CPS est interrompue, les systèmes de santé risquent d'être débordés.” ACCESS-SMC est un projet sur trois ans, financé par UNITAID, qui soutient les Programmes Nationaux de Lutte contre le Paludisme pour mener à bien le premier déploiement à grande échelle… 06/03/2018 ACCESS-SMC est un projet sur trois ans, financé par UNITAID, qui soutient les Programmes Nationaux de Lutte contre le Paludisme pour mener à bien le premier déploiement à grande échelle de la Chimioprévention du paludisme saisonnier (CPS) et ainsi sauver…
28/02/2018 Newsletters A catalyst project comes to an end Through ACCESS-SMC — a three-year UNITAID-funded project — Malaria Consortium and Catholic Relief Services supported National Malaria Control Programmes to scale up access to seasonal malaria chemoprevention and save children’s… 28/02/2018 Through ACCESS-SMC — a three-year UNITAID-funded project — Malaria Consortium and Catholic Relief Services supported National Malaria Control Programmes to scale up access to seasonal malaria chemoprevention and save children’s lives across seven countries in the Sahel. This final newsletter…
27/02/2018 Case study Gassara’s story: “Health systems risk being overwhelmed by malaria if seasonal malaria chemoprevention is discontinued.” This case study from Chad highlights the impact of seasonal malaria chemoprevention. Through ACCESS-SMC — a three-year UNITAID-funded project — Malaria Consortium and Catholic Relief Services supported National Malaria Control… 27/02/2018 This case study from Chad highlights the impact of seasonal malaria chemoprevention. Through ACCESS-SMC — a three-year UNITAID-funded project — Malaria Consortium and Catholic Relief Services supported National Malaria Control Programmes to scale up access to seasonal malaria chemoprevention and…
29/11/2017 Project brief Sauver des vies – la CPS à grande échelle Le paludisme est une maladie prévisible et traitable, mais de nombreux enfants en Afrique en meurent avant leur cinquième anniversaire. Le projet ACCESS-SMC a prouvé la faisabilité et l’impact la… 29/11/2017 Le paludisme est une maladie prévisible et traitable, mais de nombreux enfants en Afrique en meurent avant leur cinquième anniversaire. Le projet ACCESS-SMC a prouvé la faisabilité et l’impact la chimioprévention du paludisme saisonnier (CPS) à grande échelle. La CPS,…
22/11/2017 Poster Transforming the malaria landscape: Results from a three-year implementation research project expanding access to seasonal malaria chemoprevention in seven Sahelian countries Malaria Consortium presented a poster detailing the results from the three-year ACCESS-SMC project at the 10th European Congress on Tropical Medicine and International Health in Antwerp, Belgium from 16–20 October… 22/11/2017 Malaria Consortium presented a poster detailing the results from the three-year ACCESS-SMC project at the 10th European Congress on Tropical Medicine and International Health in Antwerp, Belgium from 16–20 October 2017. The project focused on expanding access to seasonal malaria…
13/11/2017 Technical brief Seasonal malaria chemoprevention at scale: Saving lives Malaria is preventable and treatable, but many children in Africa still die from malaria before their fifth birthday. The ACCESS-SMC project has proven the feasibility, safety and effectiveness of seasonal… 13/11/2017 Malaria is preventable and treatable, but many children in Africa still die from malaria before their fifth birthday. The ACCESS-SMC project has proven the feasibility, safety and effectiveness of seasonal malaria chemoprevention at scale. An estimated gap of 12 to…
17/10/2017 Annual review Trustees' report and financial statements for the year to 31 March 2017 Malaria Consortium's Trustees present their report and the audited financial statements for the year which ended 31 March 2017. 17/10/2017 Malaria Consortium's Trustees present their report and the audited financial statements for the year which ended 31 March 2017.
17/10/2017 Annual review Highlights of the year 2016–2017 Our 2016–2017 highlights present a selection of key achievements and challenges for the year. The full Trustees’ report and financial statements for the year to 31 March 2017 is available… 17/10/2017 Our 2016–2017 highlights present a selection of key achievements and challenges for the year. The full Trustees’ report and financial statements for the year to 31 March 2017 is available here. View interactive version
29/09/2017 Newsletters ACCESS-SMC September 2017 newsletter Malaria Consortium has achieved high coverage of seasonal malaria chemoprevention in Burkina Faso, Chad and Nigeria. In Burkina Faso and Chad we are even reaching more children than initially targeted.… 29/09/2017 Malaria Consortium has achieved high coverage of seasonal malaria chemoprevention in Burkina Faso, Chad and Nigeria. In Burkina Faso and Chad we are even reaching more children than initially targeted. Read about the major strides the ACCESS-SMC project is making…
29/06/2017 Newsletters ACCESS-SMC June 2017 newsletter ACCESS-SMC brought together leaders in malaria prevention to reach over 6.4 million children in seven countries across the Sahel in 2016. This year, ACCESS-SMC will implement one last season to… 29/06/2017 ACCESS-SMC brought together leaders in malaria prevention to reach over 6.4 million children in seven countries across the Sahel in 2016. This year, ACCESS-SMC will implement one last season to reach roughly 3.9 million children in Burkina Faso, Chad and…
03/02/2017 Annual review Malaria Consortium strategy 2015–2019 To achieve our mission, Malaria Consortium will work with partners — including all levels of government — to improve the lives of all in Africa and Asia, especially the poorest… 03/02/2017 To achieve our mission, Malaria Consortium will work with partners — including all levels of government — to improve the lives of all in Africa and Asia, especially the poorest and most marginalised. We will target key health burdens, including…
10/01/2017 Learning brief Seasonal malaria chemoprevention: Transforming the malaria landscape in the Sahel ACCESS-SMC is a UNITAID-funded project, led by Malaria Consortium in partnership with Catholic Relief Services. This learning brief discusses the project’s approach to scaling up seasonal malaria chemoprevention (SMC) and… 10/01/2017 ACCESS-SMC is a UNITAID-funded project, led by Malaria Consortium in partnership with Catholic Relief Services. This learning brief discusses the project’s approach to scaling up seasonal malaria chemoprevention (SMC) and its impact on reducing malaria in children under five across…
20/11/2016 Annual review Trustees report and financial statements for the year to 31 March 2016 Take a look at Malaria Consortium's trustees report and financial statements for the year that ended 31 March 2016. Also read the highlights from the trustees report and financial statements… 20/11/2016 Take a look at Malaria Consortium's trustees report and financial statements for the year that ended 31 March 2016. Also read the highlights from the trustees report and financial statements 2015–2016.
20/11/2016 Annual review Highlights from the trustees report and financial statements 2015–2016 During the first operating year of Malaria Consortium’s 2015–2019 strategy, we continued to deliver on our mission to improve lives in Africa and Asia through sustainable, evidence-based programmes that combat… 20/11/2016 During the first operating year of Malaria Consortium’s 2015–2019 strategy, we continued to deliver on our mission to improve lives in Africa and Asia through sustainable, evidence-based programmes that combat targeted diseases and promote child and maternal health. This review…
08/06/2016 Advocacy briefs Making the case for seasonal malaria chemoprevention Seasonal malaria chemoprevention (SMC) is a highly effective method of malaria prevention, recommended by the World Health Organization. This advocacy brief makes the case for scaling up SMC across the… 08/06/2016 Seasonal malaria chemoprevention (SMC) is a highly effective method of malaria prevention, recommended by the World Health Organization. This advocacy brief makes the case for scaling up SMC across the Sahel region, discusses the challenges to successful scale-up, and presents…
15/12/2015 Annual review Annual review: Highlights of the year 2014–2015 In 2014–2015, we continued our work to reduce malaria deaths and incidence by helping governments tailor, innovate, adopt and apply interventions best suited to their needs. We also supported the… 15/12/2015 In 2014–2015, we continued our work to reduce malaria deaths and incidence by helping governments tailor, innovate, adopt and apply interventions best suited to their needs. We also supported the delivery of integrated community case management programmes, extended our engagement…
24/02/2014 Annual review Malaria Consortium 2003-2013: a decade in communicable disease control and child health Malaria Consortium was founded in 2003 by a small team of people with a vision - to build the capacity of malaria-endemic countries worldwide to deal with a common and… 24/02/2014 Malaria Consortium was founded in 2003 by a small team of people with a vision - to build the capacity of malaria-endemic countries worldwide to deal with a common and treatable disease that was devastating the lives of poor and…
View all publications

Sign up for our newsletters here: